JAMES HART: Open Payments
NPI 1871783522 · CLEVELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$130 in 5 payments from 4 companies in 2025. Trend: 2023 $319 · 2024 $439 · 2025 $130
Food & beverage: $130
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 1 | $42 |
| Alkermes, Inc. | 2 | $41 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
Products named: INVEGA SUSTENNA, ARISTADA, INGREZZA, CAPLYTA.
Industry payments across TN — which companies pay providers there.
